Show
Sort by
-
No association between C-reactive protein gene polymorphisms and decrease of C-reactive protein serum concentration after infliximab treatment in Crohn's disease
-
Lymphotoxin alpha gene in Crohn's disease patients: absence of implication in the response to infliximab in a large cohort study
-
Radiological sacroiliitis in Crohn's disease: A multicenter association study
-
Video capsule endoscopy in small-bowel malignancy: A multicenter Belgian study
-
A randomized placebo-controlled clinical trial of probiotics (l. Jonhsonii, La1 (R)) on early encloscopic recurrence of Crohn's disease (CD) after ileo-caecal resection
-
Rapid improvement of bone metabolism after infliximab treatment in Crohn's disease
-
Association between polymorphism in IgG Fc receptor IIIa coding gene and biological response to infliximab in Crohn's disease
-
Budesonide in collagenous colitis: A double-blind placebo-controlled trial with histologic follow-up.
-
A positive response to infliximab in Crohn disease: Association with a higher systemic inflammation before treatment but not with-308 TNF gene polymorphism.
-
NOD2/CARD15 does not influence response to infliximab in Crohn's disease.